Uncommon case of pericardial effusion
暂无分享,去创建一个
C. Mancusi | F. Pisapia | G. Simone | A. D’Amato | M. Carlino | V. Lio | A. Sforza
[1] R. Laing,et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial , 2016, The Lancet.
[2] K. Swedberg,et al. Wytyczne ESC dotyczące rozpoznawania i leczenia chorób osierdzia w 2015 roku , 2015 .
[3] Y. Adler,et al. The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. , 2015, European heart journal.
[4] A. Ristic,et al. Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis , 2013, Heart Failure Reviews.
[5] Y. Adler,et al. Management of pericardial effusion. , 2013, European heart journal.
[6] S. Hutchison,et al. Malignant pericardial effusion in a patient with prostate adenocarcinoma , 2012, BMJ Case Reports.
[7] M. Imazio. Contemporary management of pericardial diseases , 2012, Current opinion in cardiology.
[8] MassimoImazio,et al. Indicators of Poor Prognosis of Acute Pericarditis , 2007 .
[9] M. Sissons,et al. A Rare Case of Cardiac Tamponade Due to Metastatic Cancer of the Prostate , 2006 .
[10] M. Imazio,et al. Relation of acute pericardial disease to malignancy. , 2005, The American journal of cardiology.
[11] D. Baim,et al. Pericardial effusion in patients with cancer: outcome with contemporary management strategies. , 1996, Heart.
[12] C. O'connor,et al. Etiology of large pericardial effusions. , 1993, The American journal of medicine.
[13] D. Spodick,et al. Contemporary Reviews in Cardiovascular Medicine Controversial Issues in the Management of Pericardial Diseases , 2010 .